Copy
European Stroke Organisation
 

ESOC 2022 Newsletter Vol. 4

Dear Colleagues and Friends,


And that’s a wrap! ESOC 2022 was a big success for us. We can’t believe these three days are already over. What was your personal highlight? We love to hear from you on our social channels #ESOC2022.

The conference platform and ESOC 2022 app will be online until Friday, 5 August 2022, 23:59 CEST, ensuring you can take all the time you need to work through this exiting programme and watch sessions on-demand or view over 1,000 e-Posters. Do you have a colleague that would benefit from the scientific content presented at ESOC2022? Let them know that you can still register to access to all ESOC 2022 content.

For all of those who are in Lyon, we wish you a safe trip back home.
And to all of you – online or onsite – join us next year for ESOC 2023 in Munich!

News from ESOC 2022

ESOC 2022 Plenary Highlights: Friday 6 May
  • Glenzocimab, a Novel Antithrombotic, is Associated with Reduced Intracranial Hemorrhage and Mortality Rates when Combined with Standard-Of-Care Reperfusion Therapies: The ACTIMIS Study
 
  • Treatment of Hyperglycaemia in Acute Stroke: Results from the Trial of Exenatide in Acute Ischaemic Stroke (TEXAIS)
 
  • Effects of Intensive Blood Pressure Lowering on Cerebral Ischaemia: Insights from the ENCHANTED Trial
 
  • Drip-And-Ship vs Mothership Transfer Protocols i n Patients with Intracranial Hemorrhage: Secondary Analysis of RACECAT Trial
 
  • The Effects of Long-Term Oral Anticoagulant Agents for Atrial Fibrillation (AF) After Intracranial Haemorrhage (ICH): Prospective Individual Participant Data Meta-Analysis (IPDMA) of Randomised Controlled Trials
 
  • Association Of Intraventricular Fibrinolysis with Clinical Outcomes in Patients with Intracerebral Hemorrhage: An Individual Participant Data Meta-Analysis
 
  • Intravenous Thrombolysis in Patients with Ischaemic Stroke and Recent Direct Oral Anticoagulants Intake an International Collaboration
 
  • COMBINE AF: Outcomes of Patients with Atrial Fibrillation and Ischaemic Stroke Despite Receiving Oral Anticoagulation
 
  • TWIST (Tenecteplase in Wake-Up Ischaemic Stroke Trial)
 
  • Basilar Artery Occlusion CHinese Endovascular Trial (BAOCHE) 
Press Release
ESO Elections
Congratulations to ESO`s newest officers

President - Peter Kelly
President Elect - Simona Sacco
PI Interviews
Watch all of the PI Interviews and Press Presentations conducted over the past three days in the ESOC 2022 Press Portal.

Session Report: Stroke care in women: from pahophysiology to healthcare delivery

Five lectures on topics specific to stroke in women were presented in this lively session. [more...]


Session Report: Can Artificial Intelligence and Data science improve Care of Stroke? The art of the possible

The presentations in this session look at curent AI applications in stroke identification, prediction, management and treatment as well as the strengths and weaknesses of these tools. [more...]


Session Report: ESC - ESO Joint Symposium: Evaluation of cardiac source of stroke

ESO and ESC join together present a comprehensive symposium on cardiac source of stroke. [more...]

New ESO Guidelines Presented
Guideline Directory

ePoster Walks




 ePoster Walk with Dr. Jensen

ESOC 2023 - Munich

Photo Gallery

Facebook
Twitter
LinkedIn
Website
YouTube
Email
Copyright © 2022 European Stroke Organisation (ESO), All rights reserved.

Our mailing address is:
European Stroke Organisation (ESO) · Reinacherstrasse 131 · Basel 4053 · Switzerland

Unsubscribe from this list